More in Oncology

Enzastaurin fails as maintenance therapy for metastatic colorectal cancer

Reuters Health • The Doctor's Channel Daily Newscast

Enzastaurin fails as maintenance therapy for metastatic colorectal cancer
NEW YORK (Reuters Health) – In a phase 2 study of maintenance therapy for metastatic colorectal cancer, adding enzastaurin to bevacizumab plus bolus and infusional 5-fluorouracil-leucovorin (LV5FU2) did not delay progression of metastatic colorectal cancer (CRC) in patients who responded to first-line...

CIN 1 does not increase CIN 3 risk beyond HPV infection

Reuters Health • The Doctor's Channel Daily Newscast

CIN 1 does not increase CIN 3 risk beyond HPV infection
NEW YORK (Reuters Health) – Cervical intraepithelial neoplasia grade 1 (CIN 1) found on biopsy provides no information on the risk of progression to CIN 3 beyond that of a human papillomavirus (HPV) infection, researchers report in the December issue of Obstetrics and Gynecology. As a consequence,...

Cirrhosis tied to increased risk of liver cancer in diabetics

Reuters Health • The Doctor's Channel Daily Newscast

Cirrhosis tied to increased risk of liver cancer in diabetics
NEW YORK (Reuters Health) – Cirrhosis and hepatitis are associated with the occurrence of hepatocellular carcinoma (HCC) in patients with diabetes, and hepatitis C is of particular importance, Taiwanese researchers report in a November 15th online paper in The American Journal of Gastroenterology. As...

Next Page »